Dr. Richard Berri

Doctor Overview

Dr. Richard Berri is a board-certified surgical oncologist. He is the Director of the Surgical Oncology and Peritoneal Malignancies Program at St. John Hospital & Medical Center’s Van Elslander Cancer Center. As a graduate of Wayne State University School of Medicine, Dr. Berri completed his residency in general surgery at Ascension St. John Hospital. Dr. Berri also completed a fellowship in surgical oncology at The University of Texas MD Anderson Cancer Center.

Dr. Berri developed Michigan’s first program using heated intraperitoneal chemotherapy (HIPEC) for patients with carcinomatosis from colorectal, appendiceal, gastric, ovarian, mesothelioma and other select cancers. His focus also includes:

• Hepatocellular carcinoma
• Cholangiocarcinoma
• Gallbladder cancer
• Primary or metastatic liver tumors
• Small intestine
• Peritoneal malignancies
• Neuroendocrine tumors
• Adrenal tumors
• Melanoma
• Sarcoma

In addition to Dr. Berri’s clinical work, his research has been published in a dozen peer-reviewed articles. Medical journals that published Dr. Berri’s research include American Journal of Surgery, Annals of Surgical Oncology and World Journal of Gastrointestinal Endoscopy.

Doctor Fast Facts

Main Specialty: Surgical Oncology

Other Interests & Specialties: Heated intraperitoneal chemotherapy (HIPEC), hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, primary or metastatic liver tumors, gastric, colorectal, small intestine, peritoneal mesothelioma, neuroendocrine tumors, adrenal tumors, melanoma and sarcoma.

Certifications, Awards & Accolades: American Board of Surgery Certification in Surgery

Education & Experience:

• Medical Degree from Wayne State University School of Medicine
• Internship at Ascension St. John Hospital
• Residency in General Surgery at Ascension St. John Hospital
• Fellowship in Surgical Oncology at The University of Texas MD Anderson Cancer Center

Languages Spoken:

• English
• Spanish

Publications

The diagnosis and staging of pancreatic cancer: A comparison of endoscopic ultrasound and computed tomography with pancreas protocol. The American Journal of Surgery. March 2018;215(3):472-475. doi: 10.1016/j.amjsurg.2017.11.021

Establishing a complex surgical oncology program with low morbidity and mortality at a community hospital. The American Journal of Surgery. March 2015;209(3):536-41. doi: 10.1016/j.amjsurg.2014.10.015

Intraoperative Fluid Resuscitation Strategies in Pancreatectomy: Results from 38 Hospitals in Michigan. Annals of Surgical Oncology. September 2016;2016;23(9):3047-55. doi: 10.1245/s10434-016-5235-y

Peritoneal Surface Disease Severity Score as a predictor of resectability in the treatment of peritoneal surface malignancies. The American Journal of Surgery. March 2014;207(3):403-7. doi: 10.1016/j.amjsurg.2013.09.021

Role of preoperative endoscopic ultrasound-guided fine-needle tattooing of a pancreatic head insulinoma. World Journal of Gastrointestinal Endoscopy. October 2014;6(10):506-509. doi: 10.4253%2Fwjge.v6.i10.506

Surgical Management of a Giant Pheochromocytoma. In Vivo (Athens, Greece). May 2018;32(3):703-706. doi: 10.21873/invivo.11297